Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
04.10.23 | Smiths News - Resilient performance despite headwinds | 313 | Edison Investment Research | Smiths News' recent trading update highlights continued growth in adjusted operating profit, which is anticipated to be at least in line with market expectations of £38.3m (Edison: £38.1m). This represents... ► Artikel lesen | |
04.10.23 | CI Games - Ready for a transformational journey | 403 | Edison Investment Research | CI Games' H123 results were reasonably robust, underpinned by continued strong back catalogue performance, especially Sniper Ghost Warrior (released in 2021) and releases from United Label. We are expecting... ► Artikel lesen | |
04.10.23 | ABC arbitrage - Equity markets remain calm | 465 | Edison Investment Research | ABC arbitrage group (ABCA) reported net income of €8.8m in H123, down 46% y-o-y, which in our view represents a reasonable result amid unfavourable market conditions. The market continues to be characterised... ► Artikel lesen | |
04.10.23 | Topps Tiles - Share gains with easing cost pressures in FY23 | 264 | Edison Investment Research | Topps Tiles' (TPT's) FY23 trading update indicates the company has delivered on consensus market profit expectations with a third consecutive year of record revenue. Management's stated 'significant... ► Artikel lesen | |
04.10.23 | Vantiva - Set to buy CommScope's Home Networks business | 754 | Edison Investment Research | Vantiva has announced its intention to buy CommScope's Home Networks business in exchange for CommScope taking a 25% stake in the enlarged group. The deal would significantly increase the scale of Vantiva's... ► Artikel lesen | |
04.10.23 | Molecure - Striving to maximise clinical potential | 373 | Edison Investment Research | Molecure has announced H123 results, including a recap of its operational activities. Management also outlined four strategic objectives for 2023-25, with the aim of creating a diversified portfolio... ► Artikel lesen | |
04.10.23 | The Biotech Growth Trust - Historic low sector valuations | 209 | Edison Investment Research | The Biotech Growth Trust (BIOG) now has two co-managers, Geoff Hsu and Josh Golomb, at global healthcare specialist OrbiMed Capital. The trust has experienced a difficult period of relative performance... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
GAMESTOP | 336 |
EVOTEC | 305 |
TUI | 224 |
NVIDIA | 185 |
DEUTSCHE BANK | 181 |
BAYER | 164 |
PLUG POWER | 148 |
NEL | 140 |
RHEINMETALL | 137 |
SIEMENS ENERGY | 119 |
BARRICK GOLD | 112 |
COMMERZBANK | 110 |
BASF | 108 |
TESLA | 107 |
VOLKSWAGEN | 98 |
RWE | 95 |
BYD | 93 |
DEUTSCHE LUFTHANSA | 89 |
ALLIANZ | 87 |
MERCEDES-BENZ | 83 |
DEUTSCHE TELEKOM | 82 |
RENK GROUP | 81 |
HEIDELBERGER DRUCK | 79 |
E.ON | 76 |
AIXTRON SE | 75 |